⟵ Back to Search Results
BGB-A317-303

Active, not recruiting

Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC

Beigene Study ID info

BGB-A317-303

ClinicalTrials.gov ID info

NCT03358875

EudraCT Number info

2018-000245-39

China Drug Trials ID info

CTR20171112

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 56

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 78

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 84

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 323

Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /local/liveht/www.beigene.us.2.0/beigene20_02172022_master_59/wp-content/themes/beigene20/single-clinical-trials.php on line 329

No Study Documents